Category: CBD

Pure Spectrum Signs CBD Deal With Kansas City Royals

Vapor Voice Archives
A new partnership with a cannabis brand to promote education about the potential therapeutic benefits of CBD has been formed by the Kansas City Royals—the second Major League Baseball (MLB) team to do so.
The Missouri-based team announced last week that it has joined forces with Pure Spectrum CBD, a company that produces hemp-derived cannabidiol products like oils and gummies, according to Marijuana Moments.
This is the second MLB team to embrace the cannabis space, coming just two months after the Chicago Cubs teamed up with the CBD sparkling beverage brand MYND DRINKS.
MLB itself announced its league-wide partnership with a popular CBD brand last year. Charlotte’s Web Holdings, one of the most recognizable hemp-derived CBD companies, signed the deal with the league to become the “Official CBD of MLB.”
“The Kansas City Royals are proud to be just the second MLB team to form a partnership with a company like Pure Spectrum,” Sarah Tourville, the team’s executive vice president and chief commercial & community impact officer, said in a press release. “For this organization, this opportunity gives us a chance to support a brand with Kansas City ties and to educate the community on the benefits of CBD.”
June 12, 2023
U.S. Representative Demands FDA Hand Over CBD Data
Credit: Anankkml
The chairman of a congressional committee is demanding that the U.S. Food and Drug Administration turn over documents relating to the agency’s decision not to regulate CBD products.
Rep. James Comer, chair of the House Oversight and Accountability Committee, sent a letter to FDA Commissioner Robert Califf on Monday, announcing an investigation into the agency’s decision and criticizing the “insufficient rationale for inaction” on CBD regulations.
The agency said in January that, after years of review since hemp and its derivatives like CBD were legalized under the 2018 Farm Bill, it determined that there is not a regulatory pathway in place to enact rules allowing the non-intoxicating cannabinoid to be marketed as a food item or dietary supplement.
It said that congressional action is required to develop CBD regulations, according to Marijuana Moment.
Prior to that announcement, Comer had pledged to confront FDA over the lack of regulations for cannabidiol in his capacity as Oversight Committee chairman.
“CBD is an increasingly popular product among adults and has seen an uptick in usage in recent years,” the letter to Califf says, adding that the World Health Organization (WHO) has found CBD to be generally safe and well-tolerated.
The chairman listed “documents and information” that he’s asking FDA to provide to the committee by May 1:
All documents, communications, and drafts related to the January 26 announcement titled “FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward.”
All documents and communications relating to the FDA’s assessment of the existing regulatory framework at issue regarding CBD.
All scientific data, reports, and research in the possession of the FDA relating to the safety of CBD products for consumption.
Congressional lawmakers in the U.S. have refiled a pair of bills meant to provide a pathway for the regulation of hemp derivatives like CBD as dietary supplements and food and beverage additives.
April 18, 2023
Temple CBD Maker Under Investigation in Australia
Credit : Ethically Enhanced
A company accused of advertising brightly packaged, Hubba Bubba-flavoured cannabis vape products to Australians through sponsored TikTok posts and selling them without checking for ID or requiring a prescription is being investigated by the country’s drugs regulator.
The Therapeutic Goods Administration (TGA) confirmed it is investigating the content and owners of the Ethically Enhanced website, which sells vapes containing cannabidiol (CBD) under the name Temple CBD Australia. A TGA spokesperson said the regulator will now “determine the most appropriate regulatory action,” reports The Guardian.
The confectionery giant Mars, which makes Hubba Bubba chewing gum, confirmed it was also “considering legal action” against the company.
Temple CBD’s targeted “sponsored posts” were active on TikTok for at least a week, despite Australia not allowing medicinal cannabis products to be advertised to the public.
After being contacted about the advertisements, TikTok banned the account for breaching its policies, but said it was the “responsibility of the advertiser to ensure that all ads posted on TikTok are legally compliant, in accordance with our advertising policy and appropriate for our community.”
April 16, 2023
Lawmakers in U.S. Congress File Bills to Regulate CBD

Credit: Dogora Sun
Congressional lawmakers in the U.S. have refiled a pair of bills meant to provide a pathway for the regulation of hemp derivatives like CBD as dietary supplements and food and beverage additives.
The two measures that were filed on Friday—the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act and the CBD Product Safety and Standardization Act—are being sponsored by Reps. Morgan Griffith and Angie Craig, according to Marijuana Moment.
Earlier versions of the bills were filed last Congress and ultimately did not advance, but advocates and industry stakeholders feel that the U.S. Food and Drug Administration’s recent announcement that it wouldn’t be taking steps to regulate CBD will put pressure on lawmakers to act this time around.
The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act would mandate that hemp, hemp-derived CBD and other derivatives from the federally legal cannabis plant would be made lawful as dietary supplements under the Federal Food, Drug, and Cosmetic Act (FDCA).
The CBD Product Safety and Standardization Act, meanwhile, would require FDA to develop rules and hold a public comment period on the maximum amount of hemp-derived CBD that could be added to a food item or beverage per serving, labeling and packaging requirements and the “conditions of intended use,” the text of the legislation states.
March 20, 2023
CBD Could Potentially Help Smokers Quit Smoking

Cannabidiol (CBD) could help tobacco users quit, according to a new study published in Chemical Research in Toxicology.
Washington State University researchers tested the effects of CBD and its major metabolite on human liver tissue and cell samples and found that it inhibited a key enzyme for nicotine metabolism. Slowing nicotine metabolism could allow users to wait longer before feeling the need for more. More research is needed, but according to Philip Lazarus, Washington State University professor of pharmaceutical sciences, the findings are promising.
“The whole mission is to decrease harm from smoking, which is not from the nicotine per se but all the carcinogens and other chemicals that are in tobacco smoke,” said Lazarus, senior author of the study. “If we can minimize that harm, it would be a great thing for human health.”
“It appears that you don’t need much CBD to see the effect,” said Lazarus.
Lazarus’ team is developing a clinical study to examine the effects of CBD on nicotine levels in smokers, measuring nicotine levels in their blood versus smokers taking a placebo over the course of six hours to eight hours. They hope to then do a much larger study looking at CBD and nicotine addiction.
February 18, 2023
Hong Kong Makes First CBD Arrest Since Start of Ban
Credit: Proxima Studio
Customs officers have made Hong Kong’s first arrest over cannabidiol (CBD) products after taking a clubhouse worker into custody when he showed up to collect a parcel from Denmark containing two bottles of the recently banned oil.
Officers found two more used bottles of the same CBD skin oil and four grams of cannabis buds from the man’s locker at the clubhouse of a residence in Yau Ma Tei on Wednesday, according to SCMP.
Combined with the banned CBD product, the haul was worth about HK$5,000 ($637).
The case was the first such arrest and seizure since CBD was added to the Dangerous Drug Ordinance, according to Isaac Tsang Yau-chuen, a senior investigator from the customs airport investigation division.
February 8, 2023
Dolly Parton Denies Any Affiliation With CBD Sales

Credit: Joe Hendrickson
Dolly Parton said in a statement that she does not sell Keto oils or CBD gummies that promise to prevent dementia.
The artist and amusement park owner made the announcement via her social media channels yesterday, after rumors claimed she was endorsing these products (realistic-looking ads were posted online, featuring photos of the singer). However, Snopes fact-checked the claims and reported them to be false and “fictional” — and now the Country music superstar has confirmed it.
“Dolly Parton is not affiliated with, has not endorsed and is not associated with any keto or CBD gummy product,” reads her Instagram statement. “She’s more the cake, cookie, and cornbread type.”
The false ads tried to direct readers to buy products like Supreme CBD Gummies, Jolly Nutrition CBD Gummies, and Proper CBD Gummies, according to Yahoo.
February 5, 2023
Hong Kong Begins Ban on CBD, Same Penalty as Heroin

Credit: Proxima Studio
Once legal in the city, Hong Kong began enforcing its ban on CBD, labeling it as a “dangerous drug” and imposing harsh penalties for its possession on Wednesday. The move is forcing fledging businesses to shut down or revamp.
THC, the psychoactive ingredient of marijuana has long been illegal in Hong Kong.
CBD was once legal in the city, and cafes and shops selling CBD-infused products were popular among young people, according to AP.
But all that has changed with the prohibition, which took effect Wednesday but had been announced by the government last year. CBD-related businesses have closed down while others have struggled to remodel their businesses. Consumers dumped what they saw as a cure for their ailments into special collection boxes set up around the city.
The new rule reflects a zero-tolerance policy toward dangerous drugs in Hong Kong, a semi-autonomous southern Chinese business hub, as well as in mainland China, where CBD was banned in 2022.
In contrast. the U.S. Food and Drug Administration recently concluded that a new regulatory pathway for cannabidiol (CBD) is needed. The regulatory agency states it will seek guidance from the U.S. Congress. The new rules would need to balance individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.
February 1, 2023
U.S. FDA to Seek Congress’ Help in CBD Regulations
“FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward”
The U.S. Food and Drug Administration has concluded that a new regulatory pathway for cannabidiol (CBD) is needed. The regulatory agency states it will seek guidance from the U.S. Congress. The new rules would need to balance individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks, according to a press release.
The FDA is also denying three citizen petitions that had asked the agency to conduct rulemaking to allow the marketing of CBD products as dietary supplements.
“A new regulatory pathway would benefit consumers by providing safeguards and oversight to manage and minimize risks related to CBD products,” the release states. “Some risk management tools could include clear labels, prevention of contaminants, CBD content limits, and measures, such as minimum purchase age, to mitigate the risk of ingestion by children. In addition, a new pathway could provide access and oversight for certain CBD-containing products for animals.”
FDA Principal Deputy Commissioner Janet Woodcock stated that a working group she chaired on the subject of CBD regulations closely examined studies related to the CBD-based drug Epidiolex, published scientific literature, information submitted to a public docket, as well as studies both conducted and commissioned by the agency.
“Given the available evidence, it is not apparent how CBD products could meet safety standards for dietary supplements or food additives,” she stated. “For example, we have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm. Therefore, we do not intend to pursue rulemaking allowing the use of CBD in dietary supplements or conventional foods.
“CBD also poses risks to animals, and people could be unknowingly exposed to CBD through meat, milk and eggs from animals fed CBD. Because it is not apparent how CBD products could meet the safety standard for substances in animal food, we also do not intend to pursue rulemaking allowing the use of CBD in animal food. A new regulatory pathway could provide access and oversight for certain CBD-containing products for animals.”
Woodcock said the FDA will continue to take action against CBD and other cannabis-derived products to “protect the public, in coordination with state regulatory partners,” when appropriate.
The U.S. House Oversight Committee plans to grill U.S. Food and Drug Administration Commissioner Robert Califf about why the agency still hasn’t developed CBD regulations.
The FDA has said it is planning to release CBD guidance this year.
January 26, 2023
U.S. House Oversight Committee to Grill FDA on CBD

Credit: Dogora Sun
The U.S. House Oversight Committee plans to grill U.S. Food and Drug Administration Commissioner Robert Califf about why the agency still hasn’t developed CBD regulations.
The FDA has said it is planning to release CBD guidance this year.
Rep. James Comer, chair of the Oversight Committee, said during an interview with the U.S. Hemp Roundtable advocacy group that his panel wants to ask Califf about the FDA’s “lack of action” on issues including hemp-derived CBD that fall under the agency’s regulatory jurisdiction, according to MJBiz Daily.
“I want to bring the FDA commissioner in front of the committee, and this is one of the things that we want to talk about,” Comer, a Republican from Kentucky, told the U.S. Hemp Roundtable.
“It’s not just their lack of action with respect to CBD and other types of hemp – it’s their inaction regarding a lot of areas of their jurisdiction.”
Comer said he believes the FDA’s focus on Covid-19 and vaccines might have prevented the agency from addressing other issues.
According to Hemp Today, the FDA has focused on enforcement rather than clarifying what the rules are.
In March, for example, the FDA and Federal Trade Commission sent letters to several CBD companies warning them about making health claims related to Covid-19.
January 23, 2023